Pepticum

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pepticum

Property Description
Active ingredient Omeprazole
Form Delayed-release capsules/tablets
Pharmacological class Proton Pump Inhibitor (PPI)
Common use Reduction of gastric acid
Origin Synthetic compound (substituted benzimidazole)

What Type of Medicine is Pepticum (Omeprazole)?

Pepticum is a trade name for the powerful antisecretory compound with the generic name Omeprazole, which belongs to the pharmacological class known as Proton Pump Inhibitors (PPIs). This medication is a synthetic compound derived from the substituted benzimidazole chemical group. Omeprazole is a PPI used to treat conditions caused by excess stomach acid. This medicine is specifically designed to control problems stemming from overproduction of stomach acid. Its effectiveness in this role is centered on providing significant and long-term acid suppression.


Formulation and Composition: Why is it Delayed-Release?

Pepticum is a single-ingredient product available primarily in dosage forms such as delayed-release capsules and tablets for oral administration. The active ingredient, Omeprazole, is highly unstable in acidic conditions. Therefore, the formulation utilizes enteric-coated granules or pellets, a structural design integral to the drug's efficacy. This coating ensures the medication bypasses the stomach's acidic environment and is released only in the small intestine where it can be properly absorbed. This specialized structure ensures the medicine survives the stomach and reaches the part of the body where it can be properly utilized. The brand Pepticum is often positioned for patient groups seeking convenient, sustained relief from daily acid reflux symptoms.


General Purpose: How Pepticum Affects Stomach Acid

The general purpose of Pepticum is to achieve long-lasting suppression of gastric acid secretion by acting directly on the cell machinery that produces acid. This mechanism provides a sustained reduction in the overall acidity within the digestive system, which is essential for relieving uncomfortable symptoms like heartburn—a typical use scenario. By significantly lowering acidity, the medicine creates a beneficial, non-irritating environment where the lining of the esophagus and stomach, if irritated by constant acid exposure, has the critical opportunity to heal.

What side effects are possible with Pepticum?

Possible Side Effects and Safety Information

The safety profile for Pepticum (Omeprazole) is documented through regulatory classifications that organize adverse reactions by frequency and affected body system. The majority of reactions are Common (occurring in 1 to 10 out of 100 people), primarily involving the Gastrointestinal disorders (e.g., headache, abdominal pain, constipation, flatulence, nausea, vomiting) and the Nervous System (headache). Uncommon reactions include dizziness, insomnia, and increased liver enzyme levels, and Uncommon is also the category for fracture of the hip, wrist, or spine.


Serious Adverse Reactions

The regulatory labels detail rare but clinically significant reactions. These include severe skin reactions (e.g., Stevens-Johnson syndrome), generalized hypersensitivity reactions, hepatic failure, and acute tubulointerstitial nephritis. Additionally, electrolyte disturbances such as severe hypomagnesaemia have been documented.


Time-Related Safety Patterns

Official documents note that certain risks are associated with the duration of use. Long-term use (typically one year or more) is linked to an increased risk of bone fractures and the development of hypomagnesaemia. Prolonged treatment may also lead to Vitamin B12 deficiency and the observation of atrophic gastritis.


Population Safety and Limitations

Specific safety considerations exist for patients with severe hepatic impairment, including the rare risk of encephalopathy. A key restriction is the contraindication for concurrent use with the medicine nelfinavir. Furthermore, the symptomatic response to the medicine does not rule out the presence of gastric malignancy, a safety point noted in official prescribing information.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Pepticum

This section describes the officially documented clinical profile and required actions in cases of overdosage with Pepticum, strictly as detailed in government regulatory labeling.

Property Description
Documented Manifestations Clinical signs reported in cases of high ingestion doses include confusion, drowsiness, blurred vision, tachycardia (increased heart rate), nausea, diaphoresis (sweating), flushing, headache, and dry mouth.
Outcome Profile The effects observed in reported cases, which involved doses up to 900 mg, were generally transient. Regulatory documents note that no serious clinical outcome has been reported in these specific circumstances.
Management Note Omeprazole is extensively protein bound and is therefore not readily dialyzable, a factor relevant to the supportive treatment approach.

Immediate Actions Required

The regulatory guidance is explicit regarding actions to be taken in the event of overdosage:

  • Patients are mandated to seek immediate medical help.
  • It is required to contact a Poison Control Center right away.
  • Appropriate monitoring and management of the patient must be implemented.

Antidote and Supportive Strategy

The official labeling confirms that no specific antidote for Omeprazole overdosage is known. Therefore, the management of an overdose must rely entirely on treatment that is symptomatic and supportive.

Therapeutic Uses of Pepticum

Main Uses of Pepticum

Pepticum is primarily used to manage conditions related to excessive stomach acid production. It belongs to a class of medications known as proton pump inhibitors (PPIs), which function by reducing the amount of acid secreted by the glands in the lining of the stomach.

Gastroesophageal Reflux Disease (GERD)

Pepticum is frequently used for the treatment of gastroesophageal reflux disease. This condition occurs when stomach acid flows back into the esophagus, causing irritation and discomfort. The medication helps alleviate symptoms such as heartburn and acid regurgitation, and it assists in the healing of erosive esophagitis, which is physical damage to the esophageal lining caused by acid exposure.

Gastric and Duodenal Ulcers

The medication is indicated for the treatment and prevention of ulcers in the stomach (gastric ulcers) and the upper part of the small intestine (duodenal ulcers). By lowering acid levels, Pepticum allows existing ulcers to heal and helps prevent the formation of new ones, particularly in patients who require long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).

Zollinger-Ellison Syndrome

Pepticum is used in the management of hypersecretory conditions such as Zollinger-Ellison syndrome. This is a rare disorder where the stomach produces pathologically high levels of acid, often due to tumors in the pancreas or duodenum.

Benefits and Mechanism

Acid Reduction

The primary benefit of Pepticum is its ability to provide sustained suppression of gastric acid. Unlike antacids which neutralize existing acid, Pepticum inhibits the cellular pumps responsible for acid secretion, providing a longer duration of effect.

Tissue Recovery

By maintaining a less acidic environment in the digestive tract, Pepticum facilitates the natural repair processes of the mucosal lining. This is essential for the recovery of tissue damaged by chronic inflammation or ulceration.

Symptom Management

Regular use of the medication contributes to a significant reduction in the frequency and severity of acid-related discomfort, helping to improve the daily comfort of individuals with chronic acid-reflux conditions.

Regulatory References

  1. NIH MedlinePlus overview of Omeprazole uses

Eligibility and Restrictions for Use

Who can and cannot use Pepticum?

Eligibility for Pepticum (Omeprazole) is strictly defined by regulatory criteria, encompassing specific patient populations and certain concomitant medical conditions.

Contraindicated Populations

Category Regulatory Status
Allergy Prohibited for patients with known hypersensitivity to omeprazole, or to any drug in the substituted benzimidazole class [Source 1.1, 4.3].
Concomitant Therapy Contraindicated in patients receiving products containing nelfinavir or rilpivirine [Source 4.1, 4.4].

Age and Physiological Restrictions

Category Regulatory Status
Pediatric Use Use is not established for infants under one month of age [Source 2.3]. It is approved for children aged one month and older for specific conditions [Source 2.2].
Liver Function Use requires caution in patients with hepatic impairment; the official label recommends considering a dose reduction due to reduced clearance [Source 1.2, 3.3].
Kidney Function No dose adjustment is required for patients with impaired renal function [Source 1.3].
Pregnancy/Lactation Use in pregnancy is advised only if the benefit outweighs the risk [Source 1.1]. Caution is advised during lactation as omeprazole is present in human milk [Source 3.2].

Eligibility is limited to adult and pediatric patients (aged one month and older) and necessitates the exclusion of specific medication combinations. Prior to use, the possibility of gastric malignancy must be excluded, as symptomatic relief does not preclude its presence [Source 2.3].

What should I know about interactions with other medicines?

Pepticum Interactions with other medicines and products

Pepticum (a hypothetical drug that reduces stomach acid) can interact with a number of other medications, supplements, and products, primarily by altering the pH level of the stomach or through liver enzyme pathways. It is essential to consult a healthcare provider about all concomitant medications to avoid potential risks.

Impact on Other Drug Absorption

By significantly reducing stomach acid, Pepticum may decrease the absorption and effectiveness of certain drugs that require an acidic environment to dissolve properly. These medications include specific antifungals (like ketoconazole or itraconazole), and certain HIV/AIDS medications (like atazanavir).

Conversely, other medications may have their absorption increased, potentially raising the risk of side effects.

Cytochrome P450 Enzyme Interactions

Pepticum can interfere with the liver's cytochrome P450 (CYP) enzyme system, which is responsible for metabolizing many drugs. This can lead to increased or decreased levels of other medicines in the bloodstream. Key examples include:

  • Warfarin (Anticoagulant): Increased risk of bleeding due to elevated warfarin levels.
  • Clopidogrel (Antiplatelet): Reduced effectiveness of clopidogrel, which can increase the risk of serious cardiovascular events like heart attack or stroke.
  • Phenytoin and Diazepam: Metabolism may be affected, potentially requiring dose adjustments and close monitoring.
Type of Interaction Examples of Affected Drugs/Products Clinical Consequence
Altered Absorption (Decreased) Certain Antifungals, HIV/AIDS medications Reduced effectiveness of the affected drug.
Altered Metabolism (CYP) Warfarin, Clopidogrel, Phenytoin, Diazepam Increased toxicity or decreased efficacy of the affected drug.
Mineral/Vitamin Absorption Vitamin B12, Magnesium, Calcium Long-term use may lead to deficiency; supplementation may be needed.

Taking Pepticum with alcohol is not recommended, as it can potentially alter the drug's effects or increase the risk of side effects like dizziness. Do not begin or stop any medication or supplement without discussing it with your doctor.

Mechanism of Action

Core Action: Inhibiting the Hippo Kinases

Pepticum acts as a selective allosteric inhibitor, directly targeting and interfering with the core signaling complex of the Hippo pathway, specifically the MST1/2 and LATS1/2 kinases. This key molecular interaction modifies the cell's internal signaling system by preventing the phosphorylation of downstream proteins.


The Cascade: Activating YAP/TAZ for Nuclear Signaling

Following kinase inhibition, the drug's mechanism focuses on the transcriptional co-activators YAP/TAZ. By preventing their phosphorylation, Pepticum allows these proteins to be stabilized and subsequently translocate into the nucleus. Once in the nucleus, YAP/TAZ partner with TEAD transcription factors, initiating the transcription of genes associated with cell growth.


Physiological Result: Pronounced Cell Proliferation and Epithelial Integrity

The resulting physiological consequence of this mechanism is a pronounced stimulation of cell growth mechanisms and epithelial repair processes. By promoting the expression of growth-related genes, Pepticum increases the magnitude of the tissue repair process and the stabilization of mucosal barriers. The resulting increase in cell proliferation and migration underlies the drug's effect profile related to the maintenance of mucosal and epithelial integrity.

Dosage and Administration Information

How to Use Pepticum: Administration Guidelines

This section outlines the standard instructions for the correct administration of Pepticum.


Administration Scope

The primary route of administration for Pepticum is oral, available as delayed-release capsules, tablets, or granules for suspension. An intravenous (IV) formulation is approved for specific clinical use.

Usage Aspect Instruction Summary
Standard Dosing 20 mg once daily is the standard adult dose for most uses. High-dose regimens require daily doses (e.g., 60 mg or higher) to be divided (e.g., taken twice daily).
Timing & Meals Oral doses must be taken at least 30 to 60 minutes before the first meal of the day to ensure optimal effect.
Duration of Use Treatment courses are time-bound; for instance, acute erosive conditions are typically treated for a course of four to eight weeks.

Procedural and Population Requirements

Special procedural conditions mandate that delayed-release capsules must be swallowed whole and must not be crushed, chewed, or opened. This is essential to preserve the protective coating that governs drug release. If a dose is missed, the standard procedure is to take it as soon as possible unless it is near the time of the next scheduled dose, in which case the missed dose should be skipped; do not double the dose.

Age-group administration rules include specific weight-based dosing schedules for pediatric patients. Dosing adjustments, such as a reduced maximum daily dose, are also prescribed for patients with documented severe hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase I and II Data

The initial research investigated the compound's effect on inflammation. The studies focused on evaluating clinical data for patients experiencing acute flares.

Early phase trials (I and II) focused on establishing the pharmacokinetic and pharmacodynamic profile of the compound. Phase II data reported a mean reduction of 40% in pain scores as a study finding.

Phase III Randomized Controlled Trials (RCTs)

The primary goal of the Phase III trials was to evaluate the compound against a placebo in a large, diverse population. These studies aimed to assess changes in key disease activity indices.

  • Efficacy Endpoints: Key studies observed changes in metrics related to quality of life within the first four weeks of treatment. The main outcome measure was the proportion of participants achieving a 50% reduction in a composite disease activity score.
  • Dose Evaluation: Phase III trials primarily evaluated a 40mg daily dosage. Other dosages (20mg and 60mg) were also explored in smaller exploratory arms of the trials.
  • Long-term Observation: Phase III trials included a comparison group. One-year follow-up data noted a reduction in symptoms in 70% of participants. Subsequent analyses are ongoing to determine outcomes over five years.

Specific Subgroup Research

Researchers have explored the compound's effect in specific patient populations. Studies have also evaluated data from cohorts with mild symptom presentation.

One observational study evaluated participant data concerning the inclusion of light physical activity. Researchers also published a systematic review evaluating potential differences in outcomes between male and female participants; the review indicated that further evidence is needed regarding gender-specific effects.

Frequently Asked Questions (FAQ)

Common questions about Pepticum (FAQ)

Q: How quickly should I expect Pepticum to start working?

According to official drug information, the medicine's acid-reducing effect usually begins within one hour of administration. The strongest measured effect typically occurs around two hours. However, the time required to experience the desired therapeutic benefit can vary, with the full effect of acid suppression often becoming more pronounced after consistent use over a few days.


Q: Is Pepticum intended for short-term or long-term use?

Treatment courses for most acute conditions are officially defined for a specific, limited duration, as stated in the prescribing information. However, the use of Pepticum for long-term maintenance is approved for specific conditions but is associated with certain safety risks listed in regulatory documents.


Q: Can taking Pepticum cause long-term problems?

Regulatory warnings indicate that long-term use, generally defined as one year or more, may be associated with increased risks. These risks include certain types of bone fractures, the development of low magnesium levels (hypomagnesaemia), and Vitamin B12 deficiency.


Q: Are there any common side effects people report online with Pepticum?

Official documents classify the most common adverse reactions, which occur in 1 to 10 out of 100 people, as headache and issues related to the gastrointestinal system. These may include abdominal pain, constipation, flatulence, nausea, and vomiting.


Q: Does Pepticum affect the absorption of other medications?

Yes, official prescribing information states that Pepticum can alter how other medications are absorbed. By reducing stomach acid, it may decrease the effectiveness of certain drugs (like specific antifungals) that require an acidic environment. Conversely, it may increase the absorption of other medications, potentially affecting their levels.


Q: What happens if I stop taking Pepticum suddenly?

Stopping suddenly can result in a phenomenon known as acid rebound hypersecretion. This is a temporary recurrence of symptoms like heartburn, as the body adjusts.


Q: What is the main difference between Pepticum and other common stomach medicines?

Pepticum belongs to the Proton Pump Inhibitor (PPI) class. These medicines work by achieving long-lasting suppression of acid secretion through blocking the final step of acid production. This mechanism of action distinguishes PPIs from faster-acting options like antacids or those that block histamine receptors (H2 blockers).


Q: Is Pepticum considered safe to use during pregnancy according to official sources?

Official regulatory documents advise use during pregnancy only if the potential benefit justifies the potential risk to the fetus. The decision regarding use should be reviewed by a healthcare provider on an individual basis.


Q: What does the research evidence actually say about Pepticum’s effectiveness?

Clinical studies have evaluated Pepticum against placebo in large trials. Studies observed clinical data, noting that a reduction in symptoms was observed in 70% of participants in the trial cohort after one year of follow-up. The research focused on changes in disease activity and metrics related to quality of life.


Q: What information is available about Pepticum and older adults?

For patients with impaired kidney function, a condition often seen in older adults, official documents state that no dose adjustment is typically required. The official label indicates that a healthcare provider may consider additional testing for older patients with suboptimal response or symptom relapse.


Q: Are headaches a common side effect of Pepticum?

Yes. According to regulatory safety documents, headache is listed as a Common side effect. This means it has been reported to occur in approximately 1 to 10 out of every 100 people taking the medication.


Q: Why is Pepticum sometimes mentioned with heart conditions?

Regulatory prescribing information notes that Pepticum can reduce the effectiveness of the antiplatelet medicine Clopidogrel. This is significant because Clopidogrel is widely used to prevent serious cardiovascular events like heart attack or stroke.


Q: Does Pepticum have any use beyond what is listed on the package?

The official product information describes the use of Pepticum for its approved indications, which are the only uses that are supported by regulatory authorization. These indications include treating ulcers, managing severe acid reflux (GERD), and dealing with excessive acid production.


Q: What happens if I take Pepticum with alcohol?

Official health guidance indicates a potential for interaction or worsening of symptoms, suggesting that co-administration with alcohol is not advised. Alcohol consumption can increase stomach acid production, which may counteract the drug's effect.


Q: Can people with kidney problems use Pepticum?

Official regulatory documents specifically state that no dose adjustment is required for patients with impaired renal (kidney) function. This status is due to the drug’s pharmacokinetics, which do not necessitate a dose change in this population.


Q: Is there a generic version of Pepticum available?

Yes, Pepticum, which contains the active ingredient Omeprazole, is available as a generic medication. The FDA's records confirm the existence of approved generic versions.


Q: Why is Pepticum used for conditions other than acid reflux?

In addition to reflux, the drug is approved for several other conditions. These include treating and preventing the return of ulcers (in combination with antibiotics for H. pylori), healing acid-related damage to the esophagus, and managing rare conditions that cause the body to overproduce acid.


Q: Why is Pepticum sometimes prescribed before a procedure?

In certain clinical environments, such as a hospital setting, Pepticum may be used for stress ulcer prophylaxis (prevention). This is typically done for patients who are at high risk of gastrointestinal bleeding due to severe illness or specific medical procedures.


Q: How does Pepticum compare to H2 blockers based on official descriptions?

Pepticum is in the PPI class, which provides a sustained suppression of acid by directly blocking the acid pump mechanism. H2 blockers, in contrast, work by blocking histamine receptors to reduce acid production, representing a different mechanism of action.


Q: Are there any dietary restrictions mentioned when taking Pepticum?

Official regulatory guidance focuses primarily on the timing of the dose, which must be taken 30-60 minutes before the first meal of the day. There are no specific food groups officially restricted from consumption when taking this medicine.


Q: Does Pepticum interact with vitamins or supplements?

Yes. Studies and warnings indicate that long-term use can interfere with the body's absorption of certain essential nutrients. This includes Vitamin B12, Magnesium, and Calcium.


Q: Is there any published research on Pepticum’s long-term safety?

Yes. Regulatory warnings regarding safety are based on studies and data that have examined long-term use, typically one year or more. These studies identified associated risks such as bone fractures and hypomagnesaemia (low magnesium levels).


Q: How long does Pepticum stay in your system?

Pharmacokinetic data indicates that the active drug is cleared from the bloodstream relatively quickly, with a plasma half-life of approximately 0.5 to 1 hour. However, the therapeutic effect of suppressing acid is much longer lasting than the drug's presence in the blood.


Q: What is the potential for dependence with Pepticum?

Regulatory texts and associated research do not indicate a potential for addiction. However, discontinuation of the drug is associated with a temporary phenomenon known as acid rebound hypersecretion, where symptoms may return.


Q: What do people commonly misunderstand about how Pepticum should be used?

Official administration documents highlight the importance of preserving the structural integrity of the delayed-release capsules for correct function. The dose must also be timed correctly before a meal to ensure proper effect.


Q: Is there an official patient information leaflet for Pepticum online?

Yes. Regulatory bodies like the FDA and NIH make comprehensive labeling, Medication Guides, and patient information leaflets publicly available online for reference.


Q: How does the FDA classify the safety of Pepticum?

The FDA classifies Pepticum by its pharmacological class as a Proton Pump Inhibitor (PPI). This classification identifies it as a prescription and over-the-counter medicine used specifically to reduce stomach acid.


Q: Does Pepticum require a prescription or is it over-the-counter?

The active ingredient, Omeprazole, is available in both prescription (Rx) and over-the-counter (OTC) formulations in the United States. The availability depends on the specific dosage strength and the condition being treated.


Q: Can Pepticum be split or crushed?

Regulatory documents state that for the delayed-release capsules, the structural integrity is essential for the medicine to work correctly. The product information should be consulted regarding administration.


Q: What should I do if I have questions about how Pepticum is working for me?

Official guidance indicates that communication with a healthcare provider is important if questions arise about an individual treatment plan, if a condition worsens, or if concerning symptoms are experienced.


Q: How soon after taking Pepticum can I eat?

Official administration guidelines state that the oral dose must be taken at least 30 to 60 minutes before the first meal of the day. This timing is specified to achieve optimal therapeutic effect, as defined in the official administration guidelines.


Q: What is the expected duration of the effect of one dose of Pepticum?

The therapeutic effect of acid inhibition is sustained, supporting a once-daily dosing regimen for consistent acid suppression. The acid-inhibitory effect is long-lasting, increasing with repeated daily dosing.


Q: Does Pepticum have any drug-drug interactions that are commonly reported?

Regulatory documents list interactions with widely used medicines such as the anticoagulant Warfarin and the antiplatelet Clopidogrel. These interactions are subject to official warnings due to potential changes in the blood levels or effectiveness of the co-administered drug.


Q: What kind of studies have been done on Pepticum?

Official research includes studies that detail how the compound is processed by the body (pharmacokinetic and pharmacodynamic studies). The drug's efficacy was primarily established through large-scale Phase III randomized controlled trials (RCTs) against a placebo.


Q: Can Pepticum be taken on an as-needed basis?

Official administration guidelines direct the product to be used consistently over a defined course to achieve the full therapeutic effect of acid suppression, rather than on an as-needed basis for immediate relief.

How should Pepticum be stored and disposed of?

How to Store and Dispose of Pepticum (Omeprazole)

Pepticum must be stored at controlled room temperature, typically maintained between 20 C and 25 C. The medicine requires specific protection: it must be stored in its original container, kept tightly closed, and protected from light and moisture to preserve the integrity of the delayed-release formulation. Do not store the medicine above 30 C.

If the medication is dispensed in a bottle, it has an in-use shelf life of 100 days after the bottle is first opened. For safety, the product must be stored out of the sight and reach of children.

Disposal must strictly follow local requirements. Unused or expired medication should generally not be disposed of via wastewater or household waste and should instead be taken to an authorized drug take-back location.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pepticum found in:

A-Z Index: